{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:37:19Z","timestamp":1787647039224,"version":"build-2736575974"},"reference-count":133,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HHSN275201300006C"],"award-info":[{"award-number":["HHSN275201300006C"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ajog.2022.11.1276","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T11:10:01Z","timestamp":1667905801000},"page":"580.e1-580.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Perturbations in kinetics of the thrombin generation assay identify women at risk of preeclampsia in the first trimester and provide the rationale for a preventive approach"],"prefix":"10.1016","volume":"228","author":[{"given":"Offer","family":"Erez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gotsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinnakorn","family":"Chaiworapongsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dereje W.","family":"Gudicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manaphat","family":"Suksai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahiana M.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piya","family":"Chaemsaithong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariachiara","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malek","family":"Al Qasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Meyyazhagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandor Gabor","family":"Than","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4448-5121","authenticated-orcid":false,"given":"Roberto","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2022.11.1276_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/JPM.2006.089","article-title":"Normal and abnormal transformation of the spiral arteries during pregnancy","volume":"34","author":"Espinoza","year":"2006","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib2","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.3109\/14767058.2014.976198","article-title":"The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small-for-gestational age, fetal death and midtrimester spontaneous abortion","volume":"28","author":"Kim","year":"2015","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib3","doi-asserted-by":"crossref","first-page":"287.e1","DOI":"10.1016\/j.ajog.2016.12.029","article-title":"Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta","volume":"216","author":"Labarrere","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib4","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.7717\/peerj.653","article-title":"Placental vascular pathology and increased thrombin generation as mechanisms of disease in obstetrical syndromes","volume":"2","author":"Mastrolia","year":"2014","journal-title":"PeerJ"},{"key":"10.1016\/j.ajog.2022.11.1276_bib5","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1471-0528.1972.tb12922.x","article-title":"On the pathogenesis of placental infarcts in pre-eclampsia","volume":"79","author":"Brosens","year":"1972","journal-title":"J\u00a0Obstet Gynaecol Br Commonw"},{"key":"10.1016\/j.ajog.2022.11.1276_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0028-2243(75)90130-6","article-title":"Uteroplacental vascular pathology","volume":"5","author":"Robertson","year":"1975","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1471-0528.1991.tb13450.x","article-title":"Placental bed spiral arteries in the hypertensive disorders of pregnancy","volume":"98","author":"Pijnenborg","year":"1991","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2022.11.1276_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0272-2712(18)30321-4","article-title":"Selected vascular lesions of the placenta","volume":"15","author":"Gersell","year":"1995","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/jmf.11.6.362.367","article-title":"Evidence of in\u00a0vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia","volume":"11","author":"Chaiworapongsa","year":"2002","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/plac.2001.0785","article-title":"Placental pathology in early onset pre-eclampsia and intra-uterine growth restriction in women with and without thrombophilia","volume":"23","author":"Sikkema","year":"2002","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2022.11.1276_bib11","doi-asserted-by":"crossref","first-page":"S945","DOI":"10.1016\/j.ajog.2021.11.1367","article-title":"Pregnancy-specific expression of protease-activated receptor 1: a therapeutic target for prevention and treatment of preeclampsia?","volume":"226","author":"Walsh","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/aogs.1978.57.s72.22","article-title":"Infarctions and intervillous thrombosis in placenta, and their association with intrauterine growth retardation","volume":"72","author":"Rolschau","year":"1978","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"10.1016\/j.ajog.2022.11.1276_bib13","first-page":"277","article-title":"Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta","volume":"7","author":"Arias","year":"1998","journal-title":"J\u00a0Matern Fetal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib14","first-page":"282","article-title":"Placental vessel morphometry in growth retardation and increased resistance of the umbilical artery Doppler flow","volume":"9","author":"Mitra","year":"2000","journal-title":"J\u00a0Matern Fetal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-2001-14068","article-title":"Intraplacental coagulation in intrauterine growth restriction: cause or result?","volume":"27","author":"Sugimura","year":"2001","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ajog.2022.11.1276_bib16","first-page":"367","article-title":"Pathological features of the placenta in fetal death","volume":"100","author":"Ornoy","year":"1976","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1080\/14767050902853117","article-title":"Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death","volume":"22","author":"Erez","year":"2009","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00003081-198528010-00004","article-title":"Intrauterine fetal demise and hemostatic failure: the fetal death syndrome","volume":"28","author":"Romero","year":"1985","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1067\/S0002-9378(03)00838-X","article-title":"Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes","volume":"189","author":"Kim","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib20","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1067\/mob.2001.117638","article-title":"The role of thrombin in preterm parturition","volume":"185","author":"Elovitz","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0002-9378(93)90499-9","article-title":"Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes","volume":"168","author":"Arias","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/jmf.11.6.368.373","article-title":"Activation of coagulation system in preterm labor and preterm premature rupture of membranes","volume":"11","author":"Chaiworapongsa","year":"2002","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib23","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1080\/14767050802361807","article-title":"A\u00a0link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor","volume":"21","author":"Erez","year":"2008","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib24","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1067\/S0002-9378(03)00576-3","article-title":"The frequency and severity of placental findings in women with preeclampsia are gestational age dependent","volume":"189","author":"Moldenhauer","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1515\/jpm-2018-0055","article-title":"The frequency and type of placental histologic lesions in term pregnancies with normal outcome","volume":"46","author":"Romero","year":"2018","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib26","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1067\/mob.2002.127720","article-title":"Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes","volume":"187","author":"Kim","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib27","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1471-0528.1999.tb08330.x","article-title":"Tissue factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia","volume":"106","author":"Bellart","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/14767050802361872","article-title":"Tissue factor and its natural inhibitor in pre-eclampsia and SGA","volume":"21","author":"Erez","year":"2008","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/10641950701548240","article-title":"Fibrinogen concentration and factor VIII activity in women with preeclampsia","volume":"26","author":"Williams","year":"2007","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2022.11.1276_bib30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1034\/j.1600-0609.2002.02691.x","article-title":"Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and pre-eclampsia","volume":"69","author":"Hayashi","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijgo.2006.07.014","article-title":"Total and free tissue factor pathway inhibitor in pregnancy hypertension","volume":"95","author":"Abdel Gader","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2022.11.1276_bib32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/14767050701495011","article-title":"Preeclampsia is associated with low concentrations of protein Z","volume":"20","author":"Erez","year":"2007","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib33","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1080\/14767058.2017.1320543","article-title":"Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes","volume":"31","author":"Erez","year":"2018","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib34","first-page":"275","article-title":"Multifunctional roles of thrombin","volume":"29","author":"Narayanan","year":"1999","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.ajog.2022.11.1276_bib35","doi-asserted-by":"crossref","first-page":"10313","DOI":"10.1016\/S0021-9258(18)67526-X","article-title":"The kinetics of inhibition of alpha-thrombin in human plasma","volume":"261","author":"Jesty","year":"1986","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ajog.2022.11.1276_bib36","first-page":"125","article-title":"Fibrinopeptide A, prothrombin fragment 1\u00a0+ 2, thrombin-antithrombin complex and D dimer before and after injection of a nonionic contrast medium (iohexol)","volume":"27","author":"Sorano","year":"1997","journal-title":"Haemostasis"},{"key":"10.1016\/j.ajog.2022.11.1276_bib37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1373\/clinchem.2015.248625","article-title":"Thrombin generation assay and its application in the Clinical Laboratory","volume":"62","author":"Tripodi","year":"2016","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajog.2022.11.1276_bib38","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1080\/14767058.2017.1323327","article-title":"The pattern and magnitude of \u201din\u00a0vivo thrombin generation\u201d differ in women with preeclampsia and in those with SGA fetuses without preeclampsia","volume":"31","author":"Erez","year":"2018","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib39","doi-asserted-by":"crossref","first-page":"S1126","DOI":"10.1016\/j.ajog.2020.11.006","article-title":"Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis","volume":"226","author":"Cruz-Lemini","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib40","article-title":"Combined anticoagulant therapy for prevention of preeclampsia and small for gestational age neonates: a systematic review and meta-analysis","author":"Kontovazainitis","year":"2022","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib41","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1160\/TH16-02-0169","article-title":"LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia. A systematic review and meta-analysis","volume":"116","author":"Mastrolia","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2022.11.1276_bib42","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/uog.15789","article-title":"Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis","volume":"47","author":"Roberge","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib43","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/uog.15921","article-title":"Low-dose aspirin plus low-molecular-weight heparin for the prevention of pre-eclampsia: yes, no or maybe","volume":"47","author":"Sotiriadis","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib44","article-title":"Evaluation of the effect of low molecular weight heparin in unexplained recurrent pregnancy loss: a meta-analysis of randomized controlled trials","author":"Wang","year":"2021","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib45","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1080\/14767058.2018.1543656","article-title":"Prevention of preeclampsia in high-risk patients with low-molecular-weight heparin: a meta-analysis","volume":"33","author":"Wang","year":"2020","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib46","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","article-title":"Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials","volume":"388","author":"Rodger","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2022.11.1276_bib47","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/bcp.13483","article-title":"Low molecular weight heparin for the prevention of severe preeclampsia: where next?","volume":"84","author":"McLaughlin","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib48","doi-asserted-by":"crossref","first-page":"S829","DOI":"10.1016\/j.ajog.2017.11.565","article-title":"The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction","volume":"218","author":"Groom","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib49","doi-asserted-by":"crossref","first-page":"S803","DOI":"10.1016\/j.ajog.2017.11.575","article-title":"A\u00a0placenta clinic approach to the diagnosis and management of fetal growth restriction","volume":"218","author":"Kingdom","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib50","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/14767050902784171","article-title":"Prenatal medicine: the child is the father of the man. 1996","volume":"22","author":"Romero","year":"2009","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/jmf.12.1.1.8","article-title":"Can heparin prevent adverse pregnancy outcome?","volume":"12","author":"Romero","year":"2002","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib52","doi-asserted-by":"crossref","first-page":"629.e1","DOI":"10.1016\/j.ajog.2015.11.015","article-title":"Maternal plasma angiogenic index-1 (placental growth factor\/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study","volume":"214","author":"Korzeniewski","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0029-7844(95)00386-X","article-title":"A\u00a0United States national reference for fetal growth","volume":"87","author":"Alexander","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib54","unstructured":"Expert Panel on the Identification, Treatment of Overweight, Obesity in Adults (US), National Heart, Lung, Blood Institute, National Institute of Diabetes, Kidney Diseases (US). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. National Institutes of Health, National Heart, Lung, and Blood Institute; 1998."},{"key":"10.1016\/j.ajog.2022.11.1276_bib55","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1097\/AOG.0000000000002046","article-title":"Committee Opinion No 700: methods for estimating the due date","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib56","first-page":"159","article-title":"ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002","volume":"99","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1081\/PRG-120021060","article-title":"Subclassification of preeclampsia","volume":"22","author":"von Dadelszen","year":"2003","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2022.11.1276_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000009989","article-title":"Endothelial cell markers and fibrinopeptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy","volume":"46","author":"Bellart","year":"1998","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ajog.2022.11.1276_bib59","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0002-9378(97)70456-3","article-title":"Changes in activated protein C resistance during normal pregnancy","volume":"177","author":"Walker","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib60","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0028-2243(89)90007-5","article-title":"Fibrinopeptide A levels in maternal and newborn plasma","volume":"30","author":"Yuen","year":"1989","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib61","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0002-9378(89)90096-3","article-title":"Enhanced thrombin generation in normal and hypertensive pregnancy","volume":"160","author":"de Boer","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/00016349509024445","article-title":"Perturbed (procoagulant) endothelium and deviations within the fibrinolytic system during the third trimester of normal pregnancy. A possible link to placental function","volume":"74","author":"S\u00f8rensen","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2022.11.1276_bib63","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.3324\/haematol.2017.185330","article-title":"Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab","volume":"103","author":"Dargaud","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.ajog.2022.11.1276_bib64","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1111\/jth.15106","article-title":"Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: combining thrombin and plasmin generation","volume":"18","author":"Valke","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2022.11.1276_bib65","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1046\/j.1538-7836.2003.00450.x","article-title":"Monitoring the bioavailability of FEIBA with a thrombin generation assay","volume":"1","author":"V\u00e1radi","year":"2003","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2022.11.1276_bib66","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1749-8090-8-154","article-title":"Preoperative thrombin generation is predictive for the risk of blood loss after cardiac surgery: a research article","volume":"8","author":"Bosch","year":"2013","journal-title":"J\u00a0Cardiothorac Surg"},{"key":"10.1016\/j.ajog.2022.11.1276_bib67","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1538-7836.2010.04146.x","article-title":"Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with postoperative bleeding","volume":"9","author":"Coakley","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2022.11.1276_bib68","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2141.2007.06738.x","article-title":"Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence","volume":"138","author":"van Hylckama Vlieg","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib69","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/ATVBAHA.111.223453","article-title":"Increased thrombin generation is associated with acute ischemic stroke but not with coronary heart disease in the elderly: the three-City cohort study","volume":"31","author":"Carcaillon","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib70","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1182\/blood-2009-09-244426","article-title":"Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants","volume":"115","author":"Devreese","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2022.11.1276_bib71","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1111\/j.1538-7836.2007.02734.x","article-title":"Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants","volume":"5","author":"Liest\u00f8l","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2022.11.1276_bib72","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1365-2249.2001.01555.x","article-title":"Detection of \u2019antiphospholipid\u2019 antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin","volume":"124","author":"Sheng","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib73","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.thromres.2011.08.004","article-title":"Thrombin generation in severe sepsis","volume":"129","author":"Petros","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2022.11.1276_bib74","doi-asserted-by":"crossref","first-page":"8227","DOI":"10.1073\/pnas.85.21.8227","article-title":"Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium","volume":"85","author":"Visser","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2022.11.1276_bib75","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/jcp.25959","article-title":"Platelet-derived microparticles regulates thrombin generation via phophatidylserine in abdominal sepsis","volume":"233","author":"Wang","year":"2018","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib76","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1111\/jth.15538","article-title":"Clinical use of thrombin generation assays","volume":"19","author":"Binder","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2022.11.1276_bib77","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.thromres.2017.06.027","article-title":"Normal pregnancy is associated with an increase in thrombin generation from the very early stages of the first trimester","volume":"157","author":"Bagot","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2022.11.1276_bib78","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1160\/TH07-05-0359","article-title":"Calibrated automated thrombin generation in normal uncomplicated pregnancy","volume":"99","author":"Rosenkranz","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2022.11.1276_bib79","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s12884-014-0384-0","article-title":"Changes in thrombin generation and D-dimer concentrations in women injecting enoxaparin during pregnancy and the puerperium","volume":"14","author":"Patel","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2022.11.1276_bib80","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619863492","article-title":"Thrombin generation in Chinese pregnant women and the effect of insulin use on thrombin generation in patients with GDM","volume":"25","author":"Dong","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.ajog.2022.11.1276_bib81","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11239-017-1572-3","article-title":"Thrombin generation test as a marker for high risk venous thrombosis pregnancies","volume":"45","author":"Joly","year":"2018","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.ajog.2022.11.1276_bib82","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.thromres.2009.09.013","article-title":"Platelet activation and endogenous thrombin potential in pre-eclampsia","volume":"125","author":"Macey","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2022.11.1276_bib83","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/ijlh.13183","article-title":"Evaluation of global haemostatic assays and fibrin structure in patients with pre-eclampsia","volume":"42","author":"Lalic-Cosic","year":"2020","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib84","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1160\/TH16-12-0949","article-title":"Elevated plasma TFPI activity causes attenuated TF-dependent thrombin generation in early onset preeclampsia","volume":"117","author":"Egan","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2022.11.1276_bib85","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/14767058.2011.591461","article-title":"Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion","volume":"25","author":"Soto","year":"2012","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib86","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/pd.3872","article-title":"The placental component in early-onset and late-onset preeclampsia in relation to fetal growth restriction","volume":"32","author":"Kovo","year":"2012","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2022.11.1276_bib87","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1538-7836.2011.04553.x","article-title":"Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT","volume":"10","author":"de Vries","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2022.11.1276_bib88","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1056\/NEJM197609092951102","article-title":"Hepatic fibrinogen deposits in pre-eclampsia. Immunofluorescent evidence","volume":"295","author":"Arias","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib89","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1681\/ASN.2007020255","article-title":"The glomerular injury of preeclampsia","volume":"18","author":"Stillman","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib90","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.preghy.2018.02.007","article-title":"Thrombotic microangiopathies of pregnancy: differential diagnosis","volume":"12","author":"Gupta","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2022.11.1276_bib91","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.fertnstert.2012.06.038","article-title":"Thrombin enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts; possible involvement in the pathogenesis of preeclampsia","volume":"98","author":"Zhao","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2022.11.1276_bib92","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1159\/000373979","article-title":"Activation of PAR-1\/NADPH oxidase\/ROS signaling pathways is crucial for the thrombin-induced sFlt-1 production in extravillous trophoblasts: possible involvement in the pathogenesis of preeclampsia","volume":"35","author":"Huang","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.ajog.2022.11.1276_bib93","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0049-3848(90)90210-4","article-title":"Elimination of antithrombin III concentrate in healthy pregnant and preeclamptic women with an acquired antithrombin III deficiency","volume":"58","author":"Weiner","year":"1990","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2022.11.1276_bib94","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1055\/s-0037-1614071","article-title":"Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. BI51.017 Study Group","volume":"84","author":"Maki","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2022.11.1276_bib95","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1055\/s-2004-815632","article-title":"Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study","volume":"29","author":"Kobayashi","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ajog.2022.11.1276_bib96","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1160\/TH03-06-0388","article-title":"Efficacy of AT in pre-eclampsia: a case-control prospective trial","volume":"91","author":"Paternoster","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2022.11.1276_bib97","doi-asserted-by":"crossref","first-page":"739.e1","DOI":"10.1016\/j.ajog.2020.08.004","article-title":"Prospective, randomized, double-blind, placebo-controlled evaluation of the pharmacokinetics, safety and efficacy of recombinant antithrombin versus placebo in preterm preeclampsia","volume":"223","author":"Paidas","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib98","doi-asserted-by":"crossref","first-page":"126.e1","DOI":"10.1016\/j.ajog.2021.01.020","article-title":"Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study","volume":"226","author":"Tarca","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib99","doi-asserted-by":"crossref","first-page":"S1145","DOI":"10.1016\/j.ajog.2021.08.027","article-title":"Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction","volume":"226","author":"McLaughlin","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib100","first-page":"B2","article-title":"Electronic address: pubs@smfm.org, Martins JG, Biggio JR, Abuhamad A. Society for Maternal-Fetal Medicine Consult Series #52: diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012)","volume":"223","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib101","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3109\/14767058.2014.963045","article-title":"Low molecular weight heparin: does it represent a clinical opportunity for preventing preeclampisa associated with fetal growth restriction?","volume":"28","author":"Ferrazzi","year":"2015","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib102","article-title":"Heparin for preventing adverse obstetrical outcomes in pregnant women with antiphospholipid syndrome, a systematic review and meta-analysis","volume":"50","author":"Guerby","year":"2021","journal-title":"J\u00a0Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.ajog.2022.11.1276_bib103","doi-asserted-by":"crossref","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","article-title":"The etiology of preeclampsia","volume":"226","author":"Jung","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib104","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.placenta.2022.03.009","article-title":"Early pathways, biomarkers, and four distinct molecular subclasses of preeclampsia: the intersection of clinical, pathological, and high-dimensional biology studies","volume":"125","author":"Than","year":"2022","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2022.11.1276_bib105","doi-asserted-by":"crossref","first-page":"S1006","DOI":"10.1016\/j.ajog.2020.10.052","article-title":"Preeclampsia has two phenotypes which require different treatment strategies","volume":"226","author":"Masini","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib106","article-title":"Prognostic value of angiogenic markers in pregnant women with chronic hypertension","volume":"10","author":"Binder","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ajog.2022.11.1276_bib107","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/clinchem\/hvab281","article-title":"Angiogenic biomarkers for risk stratification in women with preeclampsia","volume":"68","author":"Docheva","year":"2022","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajog.2022.11.1276_bib108","series-title":"Angiogenic biomarkers for the follow-up of singleton pregnancies with suspected preeclampsia","author":"G\u00f3mez Fern\u00e1ndez","year":"2022"},{"key":"10.1016\/j.ajog.2022.11.1276_bib109","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejogrb.2022.01.017","article-title":"Serum biomarkers of maternal morbidity and adverse outcome in severe pre-eclampsia","volume":"270","author":"Keepanasseril","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11010-021-04294-z","article-title":"The role of endoglin and its soluble form in pathogenesis of preeclampsia","volume":"477","author":"Margioula-Siarkou","year":"2022","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ajog.2022.11.1276_bib111","first-page":"1699","article-title":"Clinical usefulness of angiogenic factors in women with chronic kidney disease and suspected superimposed preeclampsia","volume":"35","author":"Molina-P\u00e9rez","year":"2022","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib112","article-title":"How soluble Fms-like tyrosine kinase 1 could contribute to blood-brain barrier dysfunction in preeclampsia?","volume":"12","author":"Torres-Vergara","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib113","doi-asserted-by":"crossref","first-page":"618.e1","DOI":"10.1016\/j.ajog.2022.05.043","article-title":"Diagnostic utility of serial circulating placental growth factor levels and uterine artery Doppler waveforms in diagnosing underlying placental diseases in pregnancies at high risk of placental dysfunction","volume":"227","author":"Agrawal","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib114","doi-asserted-by":"crossref","first-page":"294.e1","DOI":"10.1016\/j.ajog.2022.03.007","article-title":"Using ultrasound and angiogenic markers from a 19- to 23-week assessment to inform the subsequent diagnosis of preeclampsia","volume":"227","author":"Lai","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib115","first-page":"1576","article-title":"Placental pathology as a tool to identify women for postpartum cardiovascular risk screening following preeclampsia: a preliminary investigation","volume":"11","author":"Benton","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib116","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.preghy.2022.04.002","article-title":"Correlation between placental weight and angiogenic markers sFlt-1 and PlGF in women with preeclampsia and fetal growth restriction","volume":"28","author":"Lorenz-Meyer","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2022.11.1276_bib117","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.preghy.2022.02.002","article-title":"First-trimester prediction model for placental vascular disorders: an observational prospective study","volume":"28","author":"Monari","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2022.11.1276_bib118","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3390\/cells11030568","article-title":"The pivotal role of the placenta in normal and pathological pregnancies: a focus on preeclampsia, fetal growth restriction, and maternal chronic venous disease","volume":"11","author":"Ortega","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ajog.2022.11.1276_bib119","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.placenta.2022.02.017","article-title":"Comparison of circulating total sFLT-1 to placental-specific sFLT-1 e15a in women with suspected preeclampsia","volume":"120","author":"Rowson","year":"2022","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2022.11.1276_bib120","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4103\/IJPM.IJPM_1004_20","article-title":"Decoding placental pathology: usage of a comprehensive checklist and scoring system for reporting of placentas in the hypertensive disorders of pregnancy","volume":"65","author":"Sikchi","year":"2022","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib121","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/aogs.14345","article-title":"The association between decidual vasculopathy and abnormal uterine artery Doppler measurement","volume":"101","author":"Stevens","year":"2022","journal-title":"Acta obstet gynecol Scand"},{"key":"10.1016\/j.ajog.2022.11.1276_bib122","doi-asserted-by":"crossref","first-page":"S867","DOI":"10.1016\/j.ajog.2021.11.019","article-title":"Progress in the understanding of the pathophysiology of immunologic maladaptation related to early-onset preeclampsia and metabolic syndrome related to late-onset preeclampsia","volume":"226","author":"Robillard","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib123","first-page":"251","article-title":"The intersection of maternal metabolic syndrome, adverse pregnancy outcomes, and future metabolic health for the mother and offspring","volume":"20","author":"Girardi","year":"2022","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.ajog.2022.11.1276_bib124","article-title":"Obesity and risk of female reproductive conditions: a Mendelian randomisation study","volume":"19","author":"Venkatesh","year":"2022","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib125","first-page":"1777","article-title":"Markers of maternal insulin resistance and lipid ratios measured in early pregnancy are related to adverse fetomaternal outcomes in women treated for hyperglycemia detected in early pregnancy-data from a retrospective cohort study","volume":"11","author":"Zawiejska","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib126","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3389\/fimmu.2019.01240","article-title":"Placental galectins are key players in regulating the maternal adaptive immune response","volume":"10","author":"Balogh","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib127","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.ajog.2015.08.041","article-title":"Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance","volume":"213","author":"Kim","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.11.1276_bib128","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.placenta.2014.11.017","article-title":"Gene expression profile in cardiovascular disease and preeclampsia: a meta-analysis of the transcriptome based on raw data from human studies deposited in Gene Expression Omnibus","volume":"36","author":"Sitras","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2022.11.1276_bib129","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1055\/s-0042-1743100","article-title":"Immature platelet fraction and thrombin generation: preeclampsia biomarkers","volume":"44","author":"Moraes","year":"2022","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.ajog.2022.11.1276_bib130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/a-1717-7663","article-title":"Thrombophilia, thrombosis and thromboprophylaxis in pregnancy: for what and in whom?","volume":"42","author":"Middeldorp","year":"2022","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.ajog.2022.11.1276_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.856923","article-title":"Preeclampsia and venous thromboembolism: pathophysiology and potential therapy","volume":"9","author":"Raia-Barjat","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ajog.2022.11.1276_bib132","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/biolre\/ioaa006","article-title":"The antithrombin binding regions of heparin mediate fetal growth and reduced placental damage in the RUPP model of preeclampsia\u2020","volume":"102","author":"Wat","year":"2020","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajog.2022.11.1276_bib133","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s43032-021-00678-0","article-title":"Low molecular weight heparins (LMWH) and implications along pregnancy: a focus on the placenta","volume":"29","author":"Zullino","year":"2022","journal-title":"Reprod Sci"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937822021640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937822021640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:37:43Z","timestamp":1762079863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937822021640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":133,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0002937822021640"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2022.11.1276","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perturbations in kinetics of the thrombin generation assay identify women at risk of preeclampsia in the first trimester and provide the rationale for a preventive approach","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2022.11.1276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}